[Side effects of immune checkpoint inhibitors : Focus on pulmonary events].
1/5 보강
The development of immune checkpoint inhibitors (ICI) has revolutionized cancer treatment.
APA
Surov A, Borggrefe J (2026). [Side effects of immune checkpoint inhibitors : Focus on pulmonary events].. Radiologie (Heidelberg, Germany), 66(1), 33-40. https://doi.org/10.1007/s00117-025-01542-x
MLA
Surov A, et al.. "[Side effects of immune checkpoint inhibitors : Focus on pulmonary events].." Radiologie (Heidelberg, Germany), vol. 66, no. 1, 2026, pp. 33-40.
PMID
41402630 ↗
Abstract 한글 요약
The development of immune checkpoint inhibitors (ICI) has revolutionized cancer treatment. ICI enhance antitumor immunity by inhibiting the negative regulatory components of the T cell-mediated immune response against tumor cells. ICI are associated with less toxicity in comparison compared to chemotherapy. However, immune-mediated adverse events (iAEs) may occur during therapy with ICI. This paper focuses on pulmonary iAEs events in therapy with ICI.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.